Introduction

Piperine, a natural amide compound, is the main active substance extracted of Piper nigrum Linn. As an important natural alkaloid, piperine exhibited a wide spectrum of biological and pharmacological activities [1,2,3,4,5,6], it has anti-oxidation, antidepressant [7], toxic effect against hepatocytes [8], antiapoptotic efficacy [9], high immunomodulatory and antitumor activity [4], and has obvious effects in lowering blood fat [10]. Clinically, it can effectively control the incidence of hyperlipidemia, the treatment rate is as high as 93.3%, and it can also reduce the incidence of cardiovascular and cerebrovascular diseases. In addition to being used as a medicine, piperine is also an important organic synthetic building blocks and intermediate [11]. Its structure is mainly divided into three parts: piperidine ring, aromatic heterocyclic ring, and aliphatic hydrocarbon chain. These three places are usually considered by the researchers to be essential for their biological activity, and by modifying the structure of these parts, the biological activity of the compounds can be changed.

Essential oils (EOs) are class of complex mixtures of low molecular weight compounds extracted from various plants by steam distillation and various solvents [12]. Plant essential oils have received extensive attention from plant protection experts in recent years due to their low toxicity to mammals, low residue and extensive biological activity [13,14,15]. At present, there are many varieties of plant essential oils, and their applications are limited to the contact, fumigation and repellent of pests in confined environments such as greenhouses and warehouses [16,17,18]. In addition, essential oils can also be used as synergists, solubilizers, flavoring agents and chemical pesticides. However, most of essential oils are volatile, unstable to light and heat, easy to decompose, etc. Therefore, if the rational derivatization of essential oil molecules can be based on retaining their activity, the application of plant essential oils will undoubtedly be a significant development. Recently, during the course of our research for functional molecules based on natural essential oils [19, 20], a series of essential oil-oriented derivatives have been synthesized and approved to exhibit insecticidal or fungicidal activities, which suggest that these natural essential oils might contribute to the biological functions.

Based on this investigation, a series of piperine-oriented derivatives derived from natural phenolic compounds existed in essential oils were designed and synthesized as following strategy in Fig. 1. So, in order to explore the potential applications for these novel essential oil derivatives, we report herein the synthesis and characterization of twenty-one essential oil derivatives via simple reaction, and their antifungal activities against several phytopathogenic fungi have also been fully investigated.

Fig. 1
figure 1

Design strategy of piperine-based essential oils derivatives

Full size image

Materials and methods

Instrumentation and chemicals

All chemicals or reagents used for syntheses were of analytical reagent, and used directly without purification. Melting points (m.p.) were determined on a RY-2 apparatus and are uncorrected. 1H NMR spectra were recorded on a Brucker spectrometer at 600 MHz with the CDCl3 as the solvent and TMS as the internal standard. 13C NMR spectra were recorded on a Brucker spectrometer at 150 MHz with CDCl3 as the solvent. Mass spectra were performed on a Waters ACQUITY UPLC® H-CLASS PDA (Waters®) instrument. Column chromatography was carried out using silica gel 100–200 mesh. Analytical thin-layer chromatography (TLC) was carried out on precoated plates, and spots were visualized with ultraviolet light.

General synthesis of precursors

The key precursors including (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylic acid (n = 1) and piperic acid (n = 2) were prepared using a similar methods reported in the references [21, 22].

General synthetic procedures for target compounds

The corresponding acid bearing 1,3-benzodioxole unit (0.005 mol), phenolic compound (0.005 mol) and acetonitrile (30–60 mL) were added to a 150 mL dry round bottom flask, and 0.3 g of 4-dimethylaminopyridine was added as a catalyst, and 1.5 g of N,N′-dicyclohexylcarbodiimide was further added as a condensing agent. The reaction was stirred at room temperature to 40 °C for additional hours, and TLC traced the reaction to completion. After the completion of the reaction, the solution was dissolved in water (20 mL), and the aqueous solution was extracted with ethyl acetate (30 mL × 2) twice. The combined organic phases were washed with 5% Na2CO3 solution (30 mL × 2) and water to neutrality and dried over anhydrous Na2SO4. After filtration and concentration, the corresponding crude compound were obtained, which were purified by silica gel column-chromatography (ethyl acetate/petroleum ether) or recrystallization to give pure compounds.

5-Isopropyl-2-methylphenyl benzo[d][1,3] dioxole-5-carboxylate (1a)

1H NMR (600 MHz, CDCl3): δ = 7.85 (dd, J = 8.2, 1.8 Hz, 1H), 7.64 (d, J = 1.8 Hz, 1H), 7.19 (d, J = 7.8 Hz, 1H), 7.05 (dd, J = 7.8, 1.8 Hz, 1H), 6.98 (d, J = 1.8 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 6.08 (s, 2H), 2.93–2.88 (m, 1H), 2.18 (s, 3H), 1.25 (d, J = 6.6 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ = 164.39, 152.25, 149.59, 148.23, 148.04, 131.03, 127.51, 126.26, 124.26, 123.63, 120.04, 110.08, 108.31, 102.08, 33.74, 24.07, 15.98; MS (ESI) m/z 299.6 (M+H)+, calcd. for C18H19O4m/z = 299.1.

2-Isopropyl-5-methylphenyl benzo[d][1,3]dioxole-5-carboxylate (1b)

1H NMR (600 MHz, CDCl3): δ = 7.84–7.82 (m, 1H), 7.62 (s, 1H), 7.26–7.20 (m, 1H), 7.05 (d, J = 7.4 Hz, 1H), 6.94–6.88 (m, 3H), 6.06 (s, 2H), 3.06–3.01 (m, 1H), 2.33 (s, 3H), 1.20 (d, J = 7.2 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ = 164.72, 152.15, 148.15, 147.93, 137.17, 136.60, 127.10, 126.43, 126.12, 123.51, 122.90, 109.91, 108.20, 101.96, 27.29, 22.67, 20.85; MS (ESI) m/z 299.5 (M+H)+, calcd. for C18H19O4m/z = 299.1.

Benzo[d][1,3]dioxol-5-yl benzo[d][1,3]dioxole-5-carboxylate (1c)

1H NMR (600 MHz, CDCl3): δ = 7.80 (dd, J = 8.2, 1.8 Hz, 1H), 7.59 (d, J = 1.8 Hz, 1H), 6.90 (d, J = 8.2 Hz, 1H), 6.81 (d, J = 8.4 Hz, 1H), 6.71 (d, J = 2.4 Hz, 1H), 6.63 (dd, J = 8.4, 2.4 Hz, 1H), 6.08 (s, 2H), 6.00 (s, 2H); 13C NMR (150 MHz, CDCl3): δ = 164.82, 152.20, 147.90, 145.36, 126.19, 123.30, 114.06, 109.92, 108.15, 108.01, 103.92, 101.97, 101.71; MS (ESI) m/z 287.5 (M+H)+, calcd. for C15H11O6m/z = 287.0.

4-Allyl-2-methoxyphenyl benzo[d][1,3]dioxole-5-carboxylate (1d)

1H NMR (600 MHz, CDCl3): δ = 7.83 (dd, J = 8.2, 1.8 Hz, 1H), 7.62 (d, J = 1.8 Hz, 1H), 7.26 (s, 1H), 7.04 (d, J = 8.0 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H), 6.82 (d, J = 1.8 Hz, 1H), 6.06 (s, 2H), 6.00–5.95 (m, 1H), 5.16–5.06 (m, 2H), 3.80 (s, 3H), 3.40 (d, J = 7.2 Hz, 2H); 13C NMR (150 MHz, CDCl3): δ = 164.24, 152.02, 151.10, 147.80, 138.96, 138.21, 137.11, 126.27, 123.40, 122.66, 120.71, 116.12, 112.83, 110.12, 108.09, 101.88, 55.89, 40.12; MS (ESI) m/z 335.6 (M+Na)+, calcd. for C18H16NaO5m/z = 335.1.

2,6-Dimethoxyphenyl benzo[d][1,3]dioxole-5-carboxylate (1e)

1H NMR (600 MHz, CDCl3): δ = 7.86 (dd, J = 8.2, 1.8 Hz, 1H), 7.66 (d, J = 1.8 Hz, 1H), 7.17–7.16 (m, 1H), 6.89 (d, J = 8.2 Hz, 1H), 6.64 (d, J = 8.4 Hz, 1H), 6.06 (s, 2H), 3.80 (s, 6H); 13C NMR 1H NMR (150 MHz, CDCl3): δ = 163.88, 152.57, 151.98, 147.76, 128.95, 126.41, 126.23, 123.32, 110.29, 108.07, 104.95, 101.85, 56.19; MS (ESI) m/z 325.5 (M+Na)+, calcd. for C16H14NaO6m/z = 325.1.

2-Acetyl-5-methoxyphenyl benzo[d][1,3]dioxole-5-carboxylate (1f)

1H NMR (600 MHz, CDCl3): δ = 7.89 (d, J = 8.8 Hz, 1H), 7.84 (dd, J = 8.2, 1.8 Hz, 1H), 7.62 (d, J = 1.8 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 6.87 (dd, J = 8.8, 2.4 Hz, 1H), 6.70 (d, J = 2.4 Hz, 1H), 6.08 (s, 3H), 3.87 (s, 3H), 2.49 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 195.68, 164.42, 163.73, 152.39, 151.72, 147.98, 132.37, 126.49, 111.97, 110.07, 109.25, 108.30, 102.01, 55.75, 29.52; MS (ESI) m/z 337.4 (M+Na)+, calcd. for C17H14NaO6m/z = 337.1.

2-(Methoxycarbonyl)phenyl benzo[d][1,3]dioxole-5-carboxylate (1g)

1H NMR (600 MHz, CDCl3): δ = 8.06 (dd, J = 7.8, 1.8 Hz, 1H), 7.85 (dd, J = 8.2, 1.8 Hz, 1H), 7.64 (d, J = 1.6 Hz, 1H), 7.61–7.59 (m, 1H), 7.36–7.34 (m, 1H), 7.22 (dd, J = 8.1, 0.8 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 6.08 (s, 2H), 3.76 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 165.04, 164.68, 152.19, 150.83, 147.89, 133.80, 131.87, 126.36, 126.00, 124.00, 123.48, 123.40, 110.07, 108.22, 101.94, 52.21; MS (ESI) m/z 323.4 (M+Na)+, calcd. for C16H12NaO6m/z = 323.1.

5-Isopropyl-2-methylphenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (2a)

1H NMR (600 MHz, CDCl3): δ = 7.79 (d, J = 16.2 Hz, 1H), 7.17 (d, J = 7.8 Hz, 1H), 7.11–7.02 (m, 3H), 6.93 (s, 1H), 6.03 (s, 2H), 6.84 (d, J = 8.0 Hz, 1H), 6.48 (d, J = 15.6 Hz, 2H), 6.03 (s, 2H), 2.91–2.87 (m, 1H), 1.24 (d, J = 7.2 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ = 165.41, 149.94, 149.33, 148.03, 146.11, 128.66, 127.37, 124.85, 124.08, 119.84, 115.08, 106.60, 101.65, 33.58, 23.92, 15.86; MS (ESI) m/z 325.6 (M+H)+, calcd. for C20H21O4m/z = 325.1.

2-Isopropyl-5-methylphenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (2b)

1H NMR (600 MHz, CDCl3): δ = 7.78 (d, J = 16.2 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 7.13–7.01 (m, 4H), 6.87 (d, d, J = 7.8 Hz, 1H), 6.48 (d, J = 15.6 Hz, 1H), 6.03 (s, 2H), 3.05–3.01 (m, 1H), 2.33 (s, 3H) 1.21 (d, J = 7.2 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ = 165.88, 149.95, 148.45, 147.99, 146.12, 137.21, 136.55, 128.65, 127.07, 124.87, 122.81, 115.16, 108.63, 106.63, 101.65, 27.16, 23.08, 20.86; MS (ESI) m/z 325.5 (M+H)+, calcd. for C20H21O4m/z = 325.1.

Benzo[d][1,3]dioxol-5-yl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (2c)

1H NMR (600 MHz, CDCl3): δ = 7.68 (d, J = 15.6 Hz, 1H), 7.04–6.97 (m, 2H), 6.77 (d, J = 8.0 Hz, 1H), 6.73 (d, J = 8.4 Hz, 1H), 6.61 (d, J = 2.4 Hz, 1H), 6.53 (dd, J = 8.4, 2.4 Hz, 1H), 5.96 (s, 2H), 5.92 (s, 2H). 5.84 (s, 1H); 13C NMR (150 MHz, CDCl3): δ = 165.90, 150.02, 148.46, 148.00, 146.33, 145.29, 145.15, 128.60, 124.93, 114.97, 114.01, 108.65, 108.00, 106.60, 103.86, 101.69, 101.18; MS (ESI) m/z 313.5 (M+H)+, calcd. for C17H13O6m/z = 313.1.

4-Allyl-2-methoxyphenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (2d)

1H NMR (600 MHz, CDCl3): δ = 7.70 (d, J = 15.6 Hz, 1H), 7.05–6.92 (m, 3H), 6.79–6.69 (m, 3H), 6.42 (d, J = 15.9 Hz, 1H), 5.98–5.85 (m, 3H), 5.09–5.00 (m, 2H), 3.76 (s, 3H), 3.33 (d, J = 6.7 Hz, 2H); 13C NMR (150 MHz, CDCl3): δ = 165.32, 151.04, 149.87, 148.41, 146.15, 138.92, 138.03, 137.10, 128.76, 124.83, 122.67, 120.71, 116.15, 114.97, 112.76, 108.61, 106.65, 101.62, 55.90, 40.14; MS (ESI) m/z 361.6 (M+Na)+, calcd. for C20H18NaO5m/z = 361.1.

2,6-Dimethoxyphenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (2e)

1H NMR (600 MHz, CDCl3): δ = 7.72 (d, J = 15.6 Hz, 1H), 7.10–7.07 (m, 1H), 7.03 (d, J = 1.8 Hz, 1H), 7.00 (d, J = 7.5 Hz, 1H), 6.76 (d, J = 7.8 Hz, 1H), 6.57 (d, J = 9.0 Hz, 2H), 6.48 (d, J = 16.2 Hz, 1H), 5.96 (s, 2H), 3.76 (s, 6H); 13C NMR (150 MHz, CDCl3): δ = 164.89, 152.51, 149.82, 148.37, 146.23, 128.85, 126.22, 124.83, 114.83, 108.59, 106.69, 104.92, 101.60, 56.21; MS (ESI) m/z 351.5 (M+Na)+, calcd. for C18H16NaO6m/z = 351.1.

2-Acetyl-5-methoxyphenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (2f)

1H NMR (600 MHz, CDCl3): δ = 7.89 (d, J = 9.0 Hz, 1H), 7.82 (d, J = 15.6 Hz, 1H), 7.13 (d, J = 1.6 Hz, 1H), 7.11–7.09 (m, 1H), 6.87 (dd, J = 8.6, 2.4 Hz, 2H), 6.70 (s, 1H), 6.52 (d, J = 15.6 Hz, 1H), 6.06 (s, 2H), 3.88 (s, 3H), 2.54 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 195.96, 165.36, 163.69, 151.51, 150.14, 148.45, 147.07, 132.26, 128.51, 125.18, 123.68, 114.68, 111.89, 109.12, 108.64, 106.71, 101.69, 55.74, 29.61; MS (ESI) m/z 363.5 (M+Na)+, calcd. for C19H16NaO6m/z = 363.1.

Methyl 2-((3-(benzo[d][1,3]dioxol-5-yl)acryloyl)oxy)benzoate (2g)

1H NMR (600 MHz, CDCl3): δ = 7.97 (d, J = 9.0 Hz, 1H), 7.73 (d, J = 15.6 Hz, 1H), 7.53–7.50 (m, 1H), 7.27 (d, J = 8.0 Hz, 1H), 7.19 (s, 2H), 7.11 (d, J = 7.8 Hz, 1H), 7.04–7.00 (m, 2H), 6.77 (d, J = 8.0 Hz, 1H), 6.45 (d, J = 15.6 Hz, 1H), 5.96 (s, 2H), 3.77 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 165.61, 165.14, 150.65, 149.99, 148.43, 146.55, 133.79, 131.77, 128.67, 125.94, 125.01, 123.91, 123.56, 114.87, 108.61, 106.70, 101.66, 52.25; MS (ESI) m/z 349.4 (M+Na)+, calcd. for C18H14NaO6m/z = 349.1.

5-Isopropyl-2-methylphenyl 5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoate (3a)

1H NMR (600 MHz, CDCl3): δ = 7.83–7.79 (m, J = 15.2, 10.9 Hz, 1H), 7.09 (d, J = 7.8 Hz, 1H), 6.96–6.95 (m, 3H), 6.88–6.80 (m, 3H), 6.75–6.70 (m, 2H), 6.09 (d, J = 15.2 Hz, 1H), 5.93 (s, 2H), 2.83–2.79 (m, 1H), 2.08 (s, 3H), 1.16 (d, J = 14.6 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ = 165.51, 149.31, 148.79, 148.35, 148.04, 146.69, 141.25, 130.88, 130.40, 127.42, 124.33, 124.11, 123.34, 119.88, 119.20, 108.63, 105.93, 101.50, 33.61, 24.08, 15.92; MS (ESI) m/z 373.5 (M+Na)+, calcd. for C22H22NaO4m/z = 373.2.

2-Isopropyl-5-methylphenyl 5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoate (3b)

1H NMR (600 MHz, CDCl3): δ = 7.55–7.51 (m, 1H), 7.15 (d, J = 7.8 Hz, 1H), 6.96–6.95 (m, 2H), 6.87–6.86 (m, 2H), 6.79 (s, 1H), 6.74–6.71 (m, 2H), 6.09 (d, J = 15.0 Hz, 1H), 5.92 (s, 2H), 2.96–2.91 (m, 1H), 2.24 (s, 3H), 1.12 (d, J = 6.6 Hz, 6H); 13C NMR (150 MHz, CDCl3): δ = 166.02, 148.81, 148.36, 147.97, 146.71, 141.32, 137.22, 136.60, 130.40, 127.11, 126.46, 124.33, 123.36, 122.87, 119.27, 108.64, 105.93, 101.52, 27.17, 22.75, 20.94; MS (ESI) m/z 373.5 (M+Na)+, calcd. for C22H22NaO4m/z = 373.2.

Benzo[d][1,3]dioxol-5-yl 5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoate (3c)

1H NMR (600 MHz, CDCl3): δ = 7.57 (dd, J = 15.2, 11.0 Hz, 1H), 7.02 (d, J = 1.6 Hz, 1H), 6.94 (dd, J = 8.0, 1.6 Hz, 1H), 6.88 (d, J = 15.0 Hz, 1H), 6.81–6.77 (m, 3H), 6.66 (d, J = 2.4 Hz, 1H), 6.58 (dd, J = 8.4, 2.4 Hz, 1H), 6.09 (d, J = 15.2 Hz, 1H), 5.99 (d, J = 9.6 Hz, 4H); 13C NMR (150 MHz, CDCl3): δ = 165.84, 148.81, 148.34, 147.95, 146.76, 145.23, 145.15, 141.34, 130.37, 124.27, 123.27, 119.07, 113.99, 108.59, 107.96, 105.95, 103.86, 101.65, 101.45; MS (ESI) m/z 339.2 (M+H)+, calcd. for C19H15O6m/z = 339.1.

4-Allyl-2-methoxyphenyl 5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoate (3d)

1H NMR (600 MHz, CDCl3): δ = 7.64–7.60 (m, 1H), 7.16–7.13 (m, 1H), 7.03 (d, J = 1.8 Hz, 1H), 6.94 (dd, J = 8.0, 1.8 Hz, 1H), 6.87 (d, J = 15.6 Hz, 1H), 6.81–6.78 (m, 2H), 6.63 (d, J = 8.4 Hz, 2H), 6.22 (d, J = 15.2 Hz, 1H), 6.00 (s, 2H), 3.82 (s, 6H); 13C NMR (150 MHz, CDCl3): δ =164.83, 152.51, 148.68, 148.31, 146.65, 140.92, 130.53, 128.80, 126.14, 124.54, 123.14, 119.03, 108.55, 105.96, 104.92, 101.42, 56.19; MS (ESI) m/z 365.4 (M+H)+, calcd. for C22H21O5m/z = 365.1.

2,6-Dimethoxyphenyl 5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoate (3e)

1H NMR (600 MHz, CDCl3): δ = 7.64–7.60 (m, 1H), 7.16–7.13 (m, 1H), 7.03 (d, J = 1.8 Hz, 1H), 6.94 (dd, J = 8.0, 1.8 Hz, 1H), 6.87 (d, J = 15.6 Hz, 1H), 6.81–6.78 (m, 2H), 6.63 (d, J = 8.4 Hz, 2H), 6.22 (d, J = 15.2 Hz, 1H), 6.00 (s, 2H), 3.82 (s, 6H); 13C NMR (150 MHz, CDCl3): δ = 164.83, 152.51, 148.68, 148.31, 146.65, 140.92, 130.53, 128.80, 126.14, 124.54, 123.14, 119.03, 108.55, 105.96, 104.92, 101.42, 56.19; MS (ESI) m/z 377.4 (M+Na)+, calcd. for C20H18NaO6m/z = 377.1.

2-Acetyl-5-methoxyphenyl 5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoate (3f)

1H NMR (600 MHz, CDCl3): δ = 7.86 (d, J = 8.8 Hz, 1H), 7.63 (dd, J = 15.2, 11.0 Hz, 1H), 7.03 (d, J = 1.6 Hz, 1H), 6.98–6.87 (m, 3H), 6.86–6.78 (m, 4H), 6.66 (d, J = 2.5 Hz, 1H), 6.18 (d, J = 15.2 Hz, 1H), 6.00 (s, 2H), 3.85 (s, 3H), 2.51 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 192.87, 165.23, 163.65, 151.54, 148.89, 148.36, 147.49, 141.78, 132.19, 130.34, 124.26, 123.71, 117.79, 111.86, 109.06, 108.60, 105.98, 101.47, 55.71, 29.69; MS (ESI) m/z 389.4 (M+Na)+, calcd. for C21H18NaO6m/z = 389.1.

Methyl 2-((5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienoyl)oxy)benzoate (3g)

1H NMR (600 MHz, CDCl3): δ = 7.95 (dd, J = 7.8, 1.8 Hz, 1H), 7.59–7.46 (m, 2H), 7.27–7.21 (m, 1H), 7.08 (dd, J = 8.2, 0.8 Hz, 1H), 6.95 (d, J = 1.6 Hz, 1H), 6.87 (dd, J = 8.0, 1.6 Hz, 1H), 6.81 (d, J = 15.6 Hz, 1H), 6.76–6.68 (m, 2H), 6.12 (d, J = 15.2 Hz, 1H), 5.92 (s, 4H), 3.76 (s, 2H); 13C NMR (150 MHz, CDCl3): δ = 164.51, 164.12, 149.61, 147.76, 147.31, 145.94, 140.29, 132.71, 130.70, 129.39, 124.85, 123.40, 122.89, 122.53, 122.22, 118.00, 107.55, 104.93, 100.43, 51.20; MS (ESI) m/z 375.5 (M+Na)+, calcd. for C20H16NaO6m/z = 375.1.

Biological assay

The in vitro fungicidal activities of the target compounds 1a–3g against Rhizoctonia solani, Fusarium graminearum, Phomopsis adianticola, Alternaria tenuis Nees, Phytophthora capsici and Gloeosporium theae-sinensis were evaluated using mycelium growth rate test, and all the procedure for bioassay were according to the methods reported in literature [23].

Results and discussion

Synthesis

A series of novel compounds 1a–g, 2a–g and 3a–g derived from natural phenolic compounds existed in essential oils based on piperine scaffold can be synthesized by a mild and simple method as described in Scheme 1. In brief, the intermediate (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylic acid (n = 1) can be prepared using piperonal as starting materials [21], and the other intermediate piperic acid (n = 2) was synthesized via basic hydrolysis reaction of piperine [22]. Then, all three acids were coupling with various essential oils molecules to obtain the corresponding esters using an optimization method.

Scheme 1
scheme 1

Synthetic route for intermediates and target molecules

Full size image

To achieve the above goal for these essential oil derivatives, the initial experiment was optimized, and the different reaction conditions have been explored (Table 1). As can be seen from Table 1 (Entry 6 and 7), when the condensation system is EDCI/HOBT or CDI/DIPEA, TLC analysis showed that no obvious product was produced, however, the yields are improved when the condensation reactions are performed under the DCC/DMAP system. With this condition (DCC/DMAP) in hand, the solvent is further screened, and an equal volume of acetonitrile, tetrahydrofuran and dichloromethane are used as solvents. The reaction time and temperature are the same. The relationship between solvent and yield was obtained, as shown in Table 1, when acetonitrile was the solvent, the yield was the highest. In order to investigate the effect of the target compound yield on the reaction temperature, the experiment was carried out at a reaction temperature of 40 °C, 60 °C, and 90 °C, respectively. The results show that the yield gradually decreases with increasing temperature, and the yield is highest at 40 °C. Finally, we determined the optimal synthetic conditions for the synthesis of pepper acid-directed essential oil derivatives: DCC/DMAP is a catalytic condensation system, the solvent is acetonitrile, the reaction temperature is 40 °C, and the yield of the target compound is 83.40%.

Table 1 The optimal reaction conditions of piperic acid and carvacrol
Full size table

All of the new natural phenolic derivatives were synthesized according to the optimal conditions described above, and the structures of all the obtained compounds in this study were confirmed by satisfactory spectral analysis, including 1H NMR, 13C NMR, ESI–MS. The chemical formulas of all compounds were described in Table 2, and their chemical structures and basic physicochemical properties were summarized in “Materials and methods”.

Table 2 The chemical structure of target compounds 1a–3g
Full size table

Spectrum analyses

The structures of all target compounds 1a–3g were confirmed by 1H NMR, 13C NMR (Additional file 1) and mass spectrometry, and their structures were well consistent with all the spectral data. A representative 1H NMR spectrum of 1c is shown in Fig. 2, and each hydrogen shows a characteristic absorption peak. The methylene group on the piperine skeleton was not affected by other H in the ortho position, and a single peak appeared at 6.06 ppm, and the H of the benzene ring showed between 7.81 and 6.62 ppm.

Fig. 2
figure 2

Representative 1H NMR spectra for compound 1c

Full size image

Biological activity

Primary screening test

In this study, all essential oil derivatives 1a–g, 2a–g, and 3a–g were screened for their antifungal activities in vitro against six common plant pathogenic fungi (Rhizoctonia solani, Fusarium graminearum, Alternaria tenuis Nees, Gloeosporium theae-sinensis, Phytophthora capsici, Phomopsis adianticola), and the preliminary screening results were outlined in Table 3.

Table 3 In vitro fungicidal activity of target compounds 1a–3g
Full size table

Generally, as shown in Table 3, the preliminary assay illustrated that some compounds of the essential oil derivatives based on piperine displayed good inhibitory activities against some tested fungal strains, and we also can find that some of the target compounds have better inhibitory activities than piperine and carbendazim at the concentration of 100 µg/mL. Notably, six compounds displayed fungicidal activity more than 40% against Rhizoctonia solani, especially compound 1f displayed an 65.00% inhibition rate, better than that of piperine (63.13%). Three compounds displayed fungicidal activity more than 40% against Fusarium graminearum, except compound 2b displayed an 62.61% inhibition rate, better than that of piperine (53.04%). Four compounds displayed fungicidal activity more than 40% against Alternaria tenuis Nees, except compound 1d displayed 71.07% inhibition rate, better than that of the piperine (66.12%) and carbendazim (13.22%). Five compounds displayed fungicidal activity more than 40% against Gloeosporium theae-sinensis, 2b displayed an 66.92% inhibition rate, which is less than the activity of piperine (76.92%). Four compounds displayed fungicidal activity more than 40% against Phytophthora capsici, except compound 2b displayed an 100% inhibition rate, which is much greater than the piperine (41.88%) and carbendazim (34.27%). Four compounds displayed fungicidal activity more than 40% against Phomopsis adianticola, except compound 2b displayed an 100% inhibition rate, far superior to the piperine (29.63%).

Secondary screening test

The preliminary assay indicated many of the target compounds exhibited good fungicidal activities compared to the commercial fungicide carbendazim, in order to further investigate the potential fungicidal activities, we thus selected some compounds like 1a, 1b, 1c, 1d, 1g, 2a, 2b, 2g to have further exploration in such a situation, and compared the values of IC50 with piperine and carbendazim at different concentrations. The fungicidal activities expressed as IC50 values for highly potential compounds are listed in Table 4, which indicated some compounds had good inhibitory effects. As shown in Table 4, compounds 1a, 1g, 2b, 2g (IC50 = 11.21, 87.66, 7.79, 97.84 μg/mL) all displayed good inhibitory effects on Phytophthora capsici compared with the positive control carbendazim (IC50 > 100 μg/mL). Compounds 1a and 2b displayed good inhibitory effects compared with the piperine (IC50 = 34.87 μg/mL). In particular, 2b exhibits a broad spectrum of bacteriostatic activity.

Table 4 The IC50 of some compounds against the plant pathogen fungi
Full size table

In addition, the Fig. 3 indicated the inhibition effects of target compounds 1a, 2b on Phomopsis adianticola compared with that of piperine and carbendazim, which confirmed that the compounds 1a and 2b displayed the superior fungicidal activities on the Phomopsis adianticola at different concentrations of 12.5, 25, 50, 100, 200 µg/mL.

Fig. 3
figure 3

Inhibition activity of compounds 1a, 2b, piperine and carbendazim on Phomopsis adianticola. a–e The concentration of compounds 1a, 2b, piperine and carbendazim are 12.5, 25, 50, 100, and 200 µg/mL; CK blank control

Full size image

Conclusions

In summary, 21 piperine-directed essential oil derivatives have been designed, synthesized and evaluated as potential fungicides. The structures of all obtained molecules were characterized by 1H-NMR, 13C-NMR and ESI–MS spectra analyses, and potential bioactivity was also assessed. Preliminary bioassay results indicate that some new compounds show better fungistatic activity than piperine. Among them, compound 2b exhibits a broad spectrum of fungicidal activity, and it is hoped that further development of a new piperine-oriented agrochemicals.